Amarin (AMRN) Could See Action on Takeover Report
Tweet
Share
E-mailGet Alerts AMRN Hot Sheet
Up)Join SI Premium – FREE
Amarin Corporation plc (NASDAQ: AMRN) could see action Wednesday following reports from the UK's Daily Mail that AstraZeneca (NYSE: AZN) plans to launch a bid for the company.
While certainly to create a stir, the article appear very speculative in nature. That, and the fact that takeover speculation has been surrounding the name for months could keep a lid on things. Also, shares of Amarin rose 4.7 percent Tuesday on - you guessed it - takeover speculation.
While certainly to create a stir, the article appear very speculative in nature. That, and the fact that takeover speculation has been surrounding the name for months could keep a lid on things. Also, shares of Amarin rose 4.7 percent Tuesday on - you guessed it - takeover speculation.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackstone (BX) Nears Deal to Sell Control of S.Korean Pharma Wholesaler Geo-young to MBK Parnters for Over $1B - Reuters
- Ibotta (IBTA) starts trading at $118, price IPO at $88
- Tesla (TSLA) continues to slide, breaks under $150
Create E-mail Alert Related Categories
Rumors, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
